Online first
Original article
Published online: 2024-10-11
Right ventricular systolic pressure predicts outcomes in patients with cardiac resynchronization therapy-defibrillators
Pubmed: 39440742
Abstract
Not available
References
- Linde C. Cardiac resynchronization in heart failure: Recent advances and their practical implications. Kardiol Pol. 2023; 81(1): 7–13.
- Galloo X, Stassen J, Hirasawa K, et al. Prognostic implications of right ventricular size and function in patients undergoing cardiac resynchronization therapy. Circ Arrhythm Electrophysiol. 2023; 16(2): e011676.
- Damy T, Ghio S, Rigby AS, et al. Interplay between right ventricular function and cardiac resynchronization therapy: An analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure). J Am Coll Cardiol. 2013; 61(21): 2153–2160.
- Campbell P, Takeuchi M, Bourgoun M, et al. Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy. Circ Heart Fail. 2013; 6(3): 435–442.
- Gąsior M, Pyka Ł, Gorol J, et al. COnteMporary Modalities In Treatment of Heart Failure: A report from the COMMIT-HF registry. Kardiol Pol. 2016; 74(6): 523–528.
- Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2010; 23(7): 685–713.
- Dyrbuś M, Pyka Ł, Kurek A, et al. Alert transmissions from remote monitoring of patients with cardiac implantable devices. JACC Clin Electrophysiol. 2023; 9(10): 2163–2165.
- Dyrbuś M, Tajstra M, Kurek A, et al. Is the last before-death alert remote monitoring transmission in patients with heart failure life-threatening? Kardiol Pol. 2022; 80(3): 286–292.
- Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021; 42(35): 3427–3520.
- Arrigo M, Huber LC, Winnik S, et al. Right ventricular failure: Pathophysiology, diagnosis and treatment. Card Fail Rev. 2019; 5(3): 140–146.
- Bourantas CV, Loh HP, Bragadeesh T, et al. Relationship between right ventricular volumes measured by cardiac magnetic resonance imaging and prognosis in patients with chronic heart failure. Eur J Heart Fail. 2011; 13(1): 52–60.
- Doyle CL, Huang DT, Moss AJ, et al. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT. Heart Rhythm. 2013; 10(10): 1471–1477.
- Storsten P, Aalen JM, Boe E, et al. Mechanical effects on right ventricular function from left bundle branch block and cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2020; 13(7): 1475–1484.
- Dawood M, Elsharkawy E, Nawar M, et al. Right ventricular response to cardiac resynchronization therapy: A three-dimensional and speckle tracking echocardiographic study. Am J Cardiol. 2023; 205: 150–161.
- Hayes DL, Boehmer JP, Day JD, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm. 2011; 8(9): 1469–1475.
- Mazurek M, Jędrzejczyk-Patej E, Lenarczyk R, et al. Do we need to monitor the percentage of biventricular pacing day by day? Int J Cardiol. 2016; 221: 81–89.
- Kjaergaard J, Ghio S, St John Sutton M, et al. Tricuspid annular plane systolic excursion and response to cardiac resynchronization therapy: Results from the REVERSE trial. J Card Fail. 2011; 17(2): 100–107.
- Sidiropoulos G, Antoniadis A, Saplaouras A, et al. Impact of baseline right ventricular function on the response to cardiac resynchronization therapy - A meta-analysis. Hellenic J Cardiol. 2023; 73: 61–68.
- Brachmann J, Hilbel T, Grünig E, et al. Ventricular arrhythmias in dilated cardiomyopathy. Pacing Clin Electrophysiol . 1997; 20(10 Pt 2): 2714–2718.
- Towbin JA, Lorts A. Arrhythmias and dilated cardiomyopathy common pathogenetic pathways? J Am Coll Cardiol. 2011; 57(21): 2169–2171.
- Kolk MZH, Narayan SM, Clopton P, et al. Reduction in long-term mortality using remote device monitoring in a large real-world population of patients with implantable defibrillators. Europace. 2023; 25(3): 969–977.
- Elming M, Nielsen J, Haarbo J, et al. Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure. Circulation. 2017; 136(19): 1772–1780.
- Boriani G, Da Costa A, Quesada A, et al. Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial. Eur J Heart Fail. 2017; 19(3): 416–425.
- Geller JC, Lewalter T, Bruun NE, et al. Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: A subanalysis of the IN-TIME trial. Clin Res Cardiol. 2019; 108(10): 1117–1127.
- Rickard J, Patel D, Park C, et al. Long-term outcomes in patients with a left ejection fraction ≤15% undergoing cardiac resynchronization therapy. JACC: Clinical Electrophysiology. 2021; 7(1): 36–46.
